In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended remissions and protection against PsA relative to other biologics.

Older patients and those with genetic risk factors were at particularly high risk of relapse and had poorer overall survival.

Across two trials, 9 of 10 frontline AML patients achieved remission when treated with mipletamig in combination with the standard of careTriplet Combination with mipletamig continues to outperform ...

Across two trials, 9 of 10 frontline AML patients achieved remission when treated with mipletamig in combination with the standard of careTriplet Combination with mipletamig continues to outperform do ...

Rodabe N. Amaria, MD, explains a trial of OBX-115, a novel engineered tumor infiltrating lymphocyte therapy, in checkpoint ...

During a working group meeting on Thursday, JICS inspecting judge Edwin Cameron said the Bail Fund would address the “injustice of being detained simply because of poverty” and make an impact on ...

In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.

The target market for XRP (CRYPTO: XRP) is the financial industry. In fact, there's another category of potential users of XRP that could demand so much of the coin that its price rises for years on ...

The Government is promoting the textile sector through initiatives like PM MITRA Parks, PLI schemes, skill development ...

The House of Representatives has approved a new VAT sharing formula, allocating 55 percent to states and 35 percent to LG ...

Ongoing Phase 1 and Phase 2 clinical programs continue to exhibit long-term durable remissions in hard-to-treat cancers, including glioblastoma (GBM) and 100% of treated Acute Myeloid Leukemia (AML) ...

It's a tough time for Canadians to start a new business. A looming recession , intensifying trade war with the United States ...